[Medical treatment for thymoma: an update].

Area of Science:

• Oncology
• Thoracic Surgery
• Medical Genetics

Context:

• Thymoma, a rare tumor of the thymus, presents significant prognostic variability.
• Accurate staging and histological classification are critical for predicting patient outcomes.
• Complete surgical resection is the cornerstone of curative treatment for thymoma.

Purpose:

• To highlight the primary prognostic factors in thymoma, including disease stage and WHO histological type.
• To emphasize the critical role of complete surgical resection in achieving disease-free survival.
• To explore the utility of neoadjuvant/palliative chemotherapy and the potential of targeted therapies based on predictive biomarkers.

Summary:

• Disease stage at diagnosis and WHO histologic classification are paramount prognostic indicators for thymoma.
• Complete surgical resection is essential for improving disease-free survival.
• Chemotherapy demonstrates high efficacy for unresectable thymoma, with potential for targeted therapies identified through genetic and receptor expression analysis.

Impact:

• Optimizing treatment strategies by identifying patients who may benefit from specific interventions, including targeted therapies.
• Improving overall survival rates for thymoma patients through personalized treatment approaches.
• Advancing the understanding of thymoma biology to refine diagnostic and therapeutic paradigms.